Halt Aging in Survivors of Blood Cancers
Recruiting
N/A
Interventional Study
Hematological Malignancy
Leukemia
Lymphoid Leukemia
Multiple Myeloma
Myeloid Leukemia
Monocytic Leukemia
Non-hodgkin Lymphoma
Other Hematologic Condition
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 180 (estimated)
- Sponsor
- University of Nebraska · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age ≥50 years
2. A history of hematological malignancy
3. Participants must be able to and willingly give informed consent
Exclusion Criteria:
1. Patients receiving intensive induction or consolidation chemotherapy. Maintenance chemotherapy, or lower-intensity chemotherapy …
Contacts